Post on 17-Nov-2020
VTSANIDAD ANIMAL
10Vigilancia Tecnológica2º trimestre 2013
Bovino
Contenido
Ovino yCaprino
Porcino Avicultura Acuicultura
Apicultura Équidos Mascotas Varios
El Boletín de Vigilancia Tecnológica en Sani-dad Animal es el resultado del trabajo conjun-to de la Oficina Española de Patentes y Marcas (OEPM) y la Plataforma Tecnológica Española de Sanidad Animal (Vet+i), quienes han au-nado esfuerzos para ofrecer a los adheridos de Vet+i y a cualquier interesado en sanidad animal, una información puntual, esquemáti-ca y de rápida lectura sobre las últimas paten-tes publicadas en este campo.
Este décimo número recoge una selección de las solicitudes de patentes publicadas a nivel internacional durante el segundo trimestre de 2013 en el ámbito de la sanidad animal, las cuales aparecen distribuidas según la especie animal de aplicación de las mismas. Asimis-mo, se incorpora un capítulo que recoge soli-citudes de patentes sobre tecnologías de apli-
cación general y contiene un apartado de enlaces a noticias de interés en materia de propiedad industrial, así como sobre las ac-tividades de la Plataforma.
El boletín, que tiene una periodicidad trimes-tral, se enmarca dentro del convenio de co-laboración suscrito por ambas organizacio-nes para facilitar, impulsar y estimular el conocimiento y la utilización de los derechos de Propiedad Industrial por parte de las or-ganizaciones y empresas adheridas a la Pla-taforma Vet+i.
Se puede acceder al listado de solicitudes de patentes para cada grupo pulsando sobre las imágenes que aparecen a continuación.
1 VTBovino
12
Nº de publicación Solicitante País de origen Contenido Técnico
CN 102670646 A 20120919
Henan Health Star Phar-maceutical Co Ltd China
Cattle effervescent tablet taking lincomycin hydro-chloride as main com-ponent and preparation process for effervescent tablet
CN 102716431 A 20121010 Univ Ningxia China
Preparation method of tra-ditional Chinese medicine plastic for treating bovine mastitis
CN 102784158 A 20121121
Sichuan Deruntong Biolog Technology Co Ltd China
Preparation method of compound synergy tylo-sin tartrate for veterinary injection
CN 102772520 A 20121114
Li Gao China Traditional Chinese medici-ne composition for pre-venting or treating bovine mastitis and preparation method of composition
Chengwei Wei China
Jianhua Xiao China
CN 102772794 A 20121114
Veterinary Res Inst Of Xin-jiang Uygur Autonomous Region Animal Sciences
Academy
China
Application of Brucellosis A19 molecular marking vaccine and immunological identification thereof
KR 20130029946 A 20130326
Green Corss Veterinary Porducts Co Ltd
South Korea
Composition for immune enhancement and immuni-ty enhancing method using the same
CN 102757942 A 20121031
Lanzhou Veterinary Res Inst Chinese Academy Of
Agriculture SciencesChina
Recombinant vaccine strain for foot-and-mouth disease type A as well as preparation method the-reof and application the-reof
CN 102793713 A 20121128
Shanghai Gongyi Veteri-nary Medicines Plant China
Lincomycin hydrochloride-spectinomycin sulfate injection and preparation method thereof
CN 102793780 A 20121128
Zhengzhou Houyi Pharma-ceutical Co Ltd China
Traditional Chinese medici-ne composition for treating milk cow mastitis and pre-paration method thereof
13
Nº de publicación Solicitante País de origen Contenido Técnico
CN 102796200 A 20121128 Univ Nanjing China
Hybrid peptide bursin adjuvant and preparation method and application thereof
CN 102895491 A 20130130
Sichuan Lianmei Biological Pharm Co Ltd China
Chinese herbal medicine ultra-fine powder used for treating mastitis compri-ses cowherb seed, radix astragali or pangolin, co-llagen or tortoise plastron, Caladium, radix isatidis, radix rhapontici seu, radix Echinopsis, and liquorice
KR 20120117715 A 20121024
Daesung Microbiological Labs Co Ltd
South Korea
Functional antibiotic com-plex composition for ani-mal use
CN 102846795 A 20130102
Veterinary Res Inst Of Xin-jiang Uygur Autonomous Region Animal Sciences
Academy
China
Chinese medicine compo-sition for preventing and treating mastitis of dairy cattle and preparation method thereof
CN 102847167 A 20130102 Univ Xinjiang Agricultural China
Construction of improved synergetic nucleic acid vaccine for preventing cow mastitis
KR 20130013712 A 20130206
Lee Seung Jun South Korea
A process for producing animal pharmaceutical comprising natural herbs and having a preventing activity of animal’s diarr-hea
Lee Hyun Jin South Korea
WO 2013040142 A2 20130321
Iogenetics Llc USA Bioinformatic processes for determination of peptide binding
Bremel Robert D USAHoman Jane USA
US 2013085137 A1 20130404
Hydromer Inc USA Topical antimicrobial com-positions and methods of using sameHydromer Inc USA
WO 2013052174 A2 20130411
Univ Pennsylvania USA Methods for preventing and treating Staphylococ-cus aureus colonization, infection, and disease
Weiser Jeffrey USA
Lijek Rebeccah S USA
WO 2013047144 A1 20130404
Nippon Soda Co Japan
Cyclic amine compound and pest control agent
Hamamoto Isami JapanTakahashi Jun JapanIwasa Takao Japan
WO 2013055674 A1 20130418
Univ Toledo USA
Method for treating infec-tions
Ronning Donald USAFranco Jimmy USA
Kang Choong-Min USA
14
Nº de publicación Solicitante País de origen Contenido Técnico
US 2013065846 A1 20130314
Soll Mark D USA
Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
Rosentel Jr Joseph K USAPate James USA
Shub Natalya USAMotwani-Tejwani Monica USA
Belansky Carol USA
US 2013101623 A1 20130425 Univ New Jersey Med USA
Attenuated mycobacterial strain as novel vaccine against tuberculosis
WO 2013055540 A1 20130418
Univ Oklahoma State USA
Non-chemotherapeutic antibiotic treatment for infections in cattle
Boileau Melanie J USAClinkenbeard Kenneth D USA
Rinosh Joshua Mani USAIandolo John J USAMussa Huda USA
CN 102836226 A 20121226
Qingdao Lvman Biolog En-gineering Co Ltd China
Traditional chinese me-dicine composition for treatment of livestock mastitis, and preparation method thereof
CN 102836311 A 20121226 Song Yongfa China Chinese herbal formula for
treating calf scours
CN 102824440 A 20121219 Univ Chengdu China
Traditional Chinese medici-ne composition for treating dairy cow mastitis and preparation method the-reof
WO 2013072882 A1 20130523
Actelion Pharmaceuticals Ltd
Switzer-land
2 -amino- 1, 8 -naphthyri-dine-3 -carboxamide de-rivatives as antimicrobial agents
WO 2013074892 A1 20130523 Merial Ltd USA
Compositions compri-sing an aryl pyrazole and a substituted imidazole, methods and uses thereof
WO 2013039857 A1 20130321
Moderna Therapeutics USA Engineered nucleic acids and methods of use the-reof
Bancel Stephane USASchrum Jason P USA
WO 2013049272 A2 20130404 Theraceutix Llc USA
Composition and method for treatment of symptoms associated with various skin conditions
5
Nº de publicación Solicitante País de origen Contenido Técnico
WO 2013049382 A2 20130404
Univ Kansas State USA
Broad-spectrum antivi-rals against 3c or 3c-like proteases of picornavirus-like supercluster: picorna-viruses, caliciviruses and coronaviruses
Univ Ohio State USAChang Kyeong-Ok USA
Kim Yunjeong USAGroutas William C USA
Hua Duy USASaif Linda J USA
Wichita State University USA
WO 2013054148 A1 20130418
Fernandez Adrian Hector Antonio Argentina Use of a bismuth ion in the
manufacture of a medica-ment for the prevention and/or treatment of the haemolytic uremic syndro-me
Soubeiran Chobet Argentina
Fernandez Hector Manuel Argentina
WO 2013059984 A1 20130502
Univ Northwest A&F China Derivative of methacryloyl-benzimidazol-one (thione) and use thereof as anti-microbial drug
Ji Zhiqin ChinaWei Shaopeng China
Wu Wenjun China
WO 2013063695 A1 20130510
Kane Biotech Inc Canada
Compositions and methods for preventing and treating oral diseases
Lovetri Karen CanadaMadhyastha Srinivasa Canada
Yakandawala Nandadeva CanadaGawande Purushottam V Canada
Froehlich Gord Canada
WO 2013067578 A1 20130516
Univ Queensland AustraliaModulators of c3a recep-torsFairlie David Australia
Reid Robert C Australia
EP 2586318 A1 20130501
United Arab Emirates Uni-versity
United Arab
Emirates
Date pit composition for the treatment of animals
WO 2013070981 A2 20130516
Univ Central Florida Res Found USA
Treating er stress related disorders by stabilizing intracellular calcium ho-meostasis
WO 2013051632 A1 20130411 Takeda Pharmaceutical Japan Nitrogen-containing fused
heterocyclic compoundWO 2013042782
A1 20130328 Takeda Pharmaceutical Japan Condensed heterocyclic compound
WO 2013059437 A1 20130425 Mars Inc USA
Inhibitors of arginase and their therapeutic applica-tions
WO 2013059606 A1 20130425
Tufts Medical Ct Inc USA Compounds and methods for the treatment of mus-cular disease, and related screening methods
Children S Hospital Boston USA
6
Nº de publicación Solicitante País de origen Contenido Técnico
WO 2013078477 A2 20130530
Payne Adam J USA Solubilization of curcu-minoid compounds and products thereof
Kurien Biji T USAScofield R Hal USA
WO 2013069765 A1 20130516 Kyowa Hakko Kirin Co Ltd Japan Nitrogenated heterocyclic
compoundES 2386474 A1
20120821 Norel Sa Spain Additives for animal food
WO 2013040649 A1 20130328
Cell Ideas Pty Ltd Australia
Therapeutics using adipose cells and cell secretions
Vesey Graham AustraliaWebster Rebecca Anne Australia
Lilischkis Richard Australia
WO 2013064681 A1 20130510 Galderma Res & Dev France
N-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use
WO 2013052001 A1 20130411 Delaval Holding Ab Sweden
Method and apparatus for detecting lameness in livestock
WO 2013069780 A1 20130516 Idemitsu Kosan Co Japan Viral infection preventive
WO 2013039861 A2 20130321
Moderna Therapeutics USA Engineered nucleic acids and methods of use the-reof
Bancel Stephane USASchrum Jason P USA
1 VTOvino y Caprino
17
Nº de publicación Solicitante País de origen Contenido Técnico
CN 102784158 A 20121121
Sichuan Deruntong Biolog Technology Co Ltd China
Preparation method of compound synergy tylo-sin tartrate for veterinary injection
KR 20130029946 A 20130326
Green Corss Veterinary Porducts Co Ltd
South Korea
Composition for immune enhancement and immuni-ty enhancing method using the same
CN 102793713 A 20121128
Shanghai Gongyi Veteri-nary Medicines Plant China
Lincomycin hydrochloride-spectinomycin sulfate injection and preparation method thereof
CN 102796200 A 20121128 Univ Nanjing China
Hybrid peptide bursin adjuvant and preparation method and application thereof
ES 2387243 A1 20120918
Univ Publica De Navarra Y En Su Nombre Y Re-
presentacion Su Rector D Antonio Perez Prados
SpainPéptidos para detectar estirpes de lentivirus
Consejo Superior Investi-gacion Spain
KR 20120117715 A 20121024
Daesung Microbiological Labs Co Ltd
South Korea
Functional antibiotic com-plex composition for ani-mal use
WO 2013040142 A2 20130321
Iogenetics Llc USA Bioinformatic processes for determination of peptide binding
Bremel Robert D USAHoman Jane USA
EP 2586318 A1 20130501
United Arab Emirates Uni-versity
United Arab
Emirates
Date pit composition for the treatment of animals
US 2013085137 A1 20130404 Hydromer Inc USA
Topical antimicrobial com-positions and methods of using same
WO 2013070981 A2 20130516
Univ Central Florida Res Found USA
Treating er stress related disorders by stabilizing intracellular calcium ho-meostasis
WO 2013051632 A1 20130411 Takeda Pharmaceutical Japan Nitrogen-containing fused
heterocyclic compound
18
Nº de publicación Solicitante País de origen Contenido Técnico
WO 2013052174 A2 20130411
Univ Pennsylvania USA Methods for preventing and treating Staphylococ-cus aureus colonization, infection, and disease
Weiser Jeffrey USA
Lijek Rebeccah S USA
WO 2013042782 A1 20130328 Takeda Pharmaceutical Japan Condensed heterocyclic
compound
WO 2013055674 A1 20130418
Univ Toledo USA
Method for treating infec-tions
Ronning Donald USAFranco Jimmy USA
Kang Choong-Min USA
WO 2013059437 A1 20130425 Mars Inc USA
Inhibitors of arginase and their therapeutic applica-tions
WO 2013059606 A1 20130425
Tufts Medical Ct Inc USA Compounds and methods for the treatment of mus-cular disease, and related screening methods
Children S Hospital Boston USA
WO 2013072882 A1 20130523
Actelion Pharmaceuticals Ltd CH
2 -amino- 1, 8 -naphthyri-dine-3 -carboxamide de-rivatives as antimicrobial agents
WO 2013069765 A1 20130516 Kyowa Hakko Kirin Co Ltd Japan Nitrogenated heterocyclic
compound
WO 2013039857 A1 20130321
Moderna Therapeutics USA Engineered nucleic acids and methods of use the-reof
Bancel Stephane USASchrum Jason P USA
WO 2013049272 A2 20130404 Theraceutix Llc USA
Composition and method for treatment of symptoms associated with various skin conditions
WO 2013054148 A1 20130418
Fernandez Adrian Hector Antonio
Argenti-na
Use of a bismuth ion in the manufacture of a medica-ment for the prevention and/or treatment of the haemolytic uremic syndro-me
Soubeiran Chobet Argenti-na
Fernandez Hector Manuel Argenti-na
WO 2013048584 A2 20130404
Univ Northeastern USA
Prodrugs for treating mi-crobial infections
Lewis Kim USAFleck Laura USA
Casadei Gabriele Italy
DE 102011055815 A1 20130529 Aicuris Gmbh & Co Kg Germany
Carboxamide-substituted heteroaryl pyrazoles and their use
WO 2013059984 A1 20130502
Univ Northwest A&F China Derivative of methacryloyl-benzimidazol-one (thione) and use thereof as anti-microbial drug
Ji Zhiqin ChinaWei Shaopeng China
Wu Wenjun China
19
Nº de publicación Solicitante País de origen Contenido Técnico
WO 2013063695 A1 20130510
Kane Biotech Inc Canada
Compositions and methods for preventing and treating oral diseases
Lovetri Karen CanadaMadhyastha Srinivasa Canada
Yakandawala Nandadeva CanadaGawande Purushottam V Canada
Froehlich Gord Canada
WO 2013067578 A1 20130516
Univ Queensland AustraliaModulators of c3a recep-torsFairlie David Australia
Reid Robert C Australia
WO 2013078477 A2 20130530
Payne Adam J USA Solubilization of curcu-minoid compounds and products thereof
Kurien Biji T USAScofield R Hal USA
WO 2013042964 A2 20130328 Cj Cheiljedang Corp South
Korea
Novel bacteriophage and antibacterial composition comprising the same
WO 2013063613 A2 20130502 Univ Maryland USA
Methods and compositions related to intracellular neutralization by igg
CN 102836226 A 20121226
Qingdao Lvman Biolog Engineering Co Ltd China
Traditional Chinese me-dicine composition for treatment of livestock mastitis, and preparation method thereof
US 2013065846 A1 20130314
Soll Mark D USA
Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
Rosentel Jr Joseph K USAPate James USA
Shub Natalya USAMotwani-Tejwani Monica USA
Belansky Carol USA
US 2013101623 A1 20130425 Univ New Jersey Med USA
Attenuated mycobacterial strain as novel vaccine against tuberculosis
WO 2013074892 A1 20130523 Merial Ltd USA
Compositions compri-sing an aryl pyrazole and a substituted imidazole, methods and uses thereof
ES 2386474 A1 20120821 Norel Sa Spain Additives for animal food
WO 2013040649 A1 20130328
Cell Ideas Pty Ltd Australia
Therapeutics using adipose cells and cell secretions
Vesey Graham AustraliaWebster Rebecca Anne Australia
Lilischkis Richard Australia
WO 2013064681 A1 20130510 Galderma Res & Dev France
N-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use
110
Nº de publicación Solicitante País de origen Contenido Técnico
WO 2013052001 A1 20130411 Delaval Holding Ab Sweden
Method and apparatus for detecting lameness in livestock
WO 2013069780 A1 20130516 Idemitsu Kosan Co Japan Viral infection preventive
WO 2013039861 A2 20130321
Moderna Therapeutics USA Engineered nucleic acids and methods of use the-reof
Bancel Stephane USASchrum Jason P USA
1 VTPorcino
11
Nº de publicación Solicitante País de origen Contenido Técnico
CN 102727903 A 20121017
Chinese Ct For Animal Disease Control And Pre-
ventionChina
Heatproof lyophilized protective agent for live vaccine JXA1-R strain for highly pathogenic porcine reproductive and res-piratory syndrome and method for preparing the same
Guangdong Dahuanong Animal Health Products
Co LtdChina
CN 102727904 A 20121017
Guangdong Dahuanong Animal Health Products
Co LtdChina
Heat resisting protecti-ve agent of bivalent live vaccine against highly pathogenic porcine repro-ductive and respiratory syndrome-pseudorabies and preparation method thereof
Chinese Ct For Animal Disease Control And Pre-
ventionChina
CN 102764435 A 20121107
Lanzhou Veterinary Res Inst Chinese Academy Of
Agriculture SciencesChina
Porcine Asian type-I foot-and-mouth disease virus inactivated vaccine adjuvant and preparation method thereof
CN 102784145 A 20121121
Sichuan Deruntong Biolog Technology Co Ltd China Veterinary compound
florfenicol injection
CN 102772503 A 20121114 Rongtao Fan China
Medicine for preventing porcine reproductive and respiratory syndrome
CN 102772508 A 20121114
Univ Qingdao Agricultural China Traditional Chinese medi-cine compound Lianweng anti-dysenteric powder for treating white scour of piglet and preparation method and application of powder
Qingdao Continent Phar-maceutical Co Ltd China
Qingdao Kdn Animal Phar-maceutical Co Ltd China
CN 102772703 A 20121114
Shanxi Shuangying Ani-mal Pharmaceutical Co
LtdChina
Drug for treating porcine reproductive and respira-tory syndrome
CN 102772790 A 20121114
Qilu Animal Health Pro-ducts Co Ltd China
Compound echinacea purpurea preparation and preparation method and application thereof
12
Nº de publicación Solicitante País de origen Contenido Técnico
KR 20130029946 A 20130326
Green Corss Veterinary Porducts Co Ltd
South Korea
Composition for immune enhancement and immu-nity enhancing method using the same
CN 102757942 A 20121031
Lanzhou Veterinary Res Inst Chinese Academy Of
Agriculture SciencesChina
Recombinant vaccine strain for foot-and-mouth disease type A as well as preparation method thereof and application thereof
CN 102776134 A 20121114
Univ Huazhong Agricul-tural China
Streptococcus suis Se-rotype 2 (SS2 for short) double-gene deleted live vaccine and its applica-tion
CN 102908613 A 20130206
Guangzhou Glam Biotech-nology Co Ltd China
New recombinant protein that acts as pig immuni-ty enhancer, comprising peptide containing speci-fic amino acid sequences corresponding to p40 su-bunit of interleukin 12B, for the prevention and treatment of swine fever virus
CN 102908615 A 20130206
Pulike Bioengineering Co Ltd China
Trivalent inactivated vaccine for preventing and treating Haemophilus infection comprises Hae-mophilus parasuis antigen and an adjuvant
CN 102908617 A 20130206
Guangzhou Glam Biotech-nology Co Ltd China
Porcine reproductive and respiratory syndrome virus (PRRSV) M protein and co-stimulatory mole-cule CD40 ligand fusion vaccine useful for pre-venting and/or treating PRRSV infection
CN 102796200 A 20121128 Univ Nanjing China
Hybrid peptide bursin adjuvant and preparation method and application thereof
KR 20120117715 A 20121024
Daesung Microbiological Labs Co Ltd
South Korea
Functional antibiotic complex composition for animal use
CN 102872321 A 20130116 Yang Gaolin China
Chinese medicinal prepa-ration for preventing and controlling porcine repro-ductive and respiratory syndrome and prepara-tion method thereof
13
Nº de publicación Solicitante País de origen Contenido Técnico
CN 102846650 A 20130102
Zhengzhou Houyi Phar-maceutical Co Ltd China
Florfenicol compound composition and prepara-tion method thereof
CN 102876620 A 20130116
Jiangsu Acad Agricultural Sci China
Nontoxic ST28 strepto-coccus suis and applica-tion thereof
CN 102876635 A 20130116
Inst Of Veterinary Medici-ne Guangdong Academy Of Agricultural Sciences
China
Haemophilus parasuis outer membrane pro-tein P5 (OMP5) resistant monoclonal antibody, hybridoma cell strain and application
CN 102876636 A 20130116
Inst Of Veterinary Medici-ne Guangdong Academy Of Agricultural Sciences
China
Monoclonal antibody of Haemophilus parasuis resistant OMP5 (outer membrane protein), hy-bridoma cell strain HP-S1E2 and application
CN 102876699 A 20130116 Univ Zhejiang China
Method for establishing transgenic cell line of tar-get genes shRNA (short hairpin ribonucleic acid) interfering propagation of porcine reproductive and respiratory syndrome viruses
CN 102864157 A 20130109
Univ Huazhong Agricul-tural China Immune protective
antigen of haemophilus parasuisWuhan Keqian Animal
Biolog Products Co Ltd China
CN 102851249 A 20130102
Inst Of Animal Science And Veterinary Medicine Shandong Academy Of Agricultural Sciences
ChinaHaemophilus parasuis LZ-20100109 strain and application thereof
WO 2013039861 A2 20130321
Moderna Therapeutics USA Engineered nucleic acids and methods of use the-reof
Bancel Stephane USASchrum Jason P USA
WO 2013040142 A2 20130321
Iogenetics Llc USA Bioinformatic processes for determination of pep-tide binding
Bremel Robert D USAHoman Jane USA
EP 2586318 A1 20130501
United Arab Emirates Uni-versity
United Arab Emi-
rates
Date pit composition for the treatment of animals
WO 2013068629 A1 20130516 Hipra Lab Sa Spain
Live attenuated strain of Actinobacillus pleurop-neumoniae
WO 2013052174 A2 20130411
Univ Pennsylvania USA Methods for preventing and treating Staphylococ-cus aureus colonization, infection, and disease
Weiser Jeffrey USA
Lijek Rebeccah S USA
114
Nº de publicación Solicitante País de origen Contenido Técnico
WO 2013055674 A1 20130418
Univ Toledo USA
Method for treating infec-tions
Ronning Donald USAFranco Jimmy USA
Kang Choong-Min USA
US 2013065846 A1 20130314
Soll Mark D USA
Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
Rosentel Jr Joseph K USAPate James USA
Shub Natalya USAMotwani-Tejwani Monica USA
Belansky Carol USA
US 2013101623 A1 20130425 Univ New Jersey Med USA
Attenuated mycobacterial strain as novel vaccine against tuberculosis
WO 2013040649 A1 20130328
Cell Ideas Pty Ltd AustraliaTherapeutics using adi-pose cells and cell secre-tions
Vesey Graham AustraliaWebster Rebecca Anne Australia
Lilischkis Richard Australia
CN 102805866 A 20121205
Henan Xinzhenghao Bio Engineering Co Ltd China
Pharmaceutic preparation for livestock and applica-tion thereof
CN 102824566 A 20121219 Xi Pujie China
Herbal composition for preventing and curing swine fever
WO 2013071456 A2 20130523
Univ Santiago Chile Chile Injectable veterinary composition for sustai-ned release of ceftiofur and florfenicol in animal species, which comprises poly(lacticcoglycolic acid) (plga) microparticles, and the method for the prepa-ration thereof
Vilos Ortiz Cristian ChileVelasquez Cumplido Luis Chile
Orihuela Diaz Pedro Chile
Rios Ramirez Miguel Chile
WO 2013072882 A1 20130523
Actelion Pharmaceuticals Ltd
Switzer-land
2 -amino- 1, 8 -na-phthyridine-3 -carboxa-mide derivatives as antimicrobial agents
WO 2013039857 A1 20130321
Moderna Therapeutics USA Engineered nucleic acids and methods of use the-reof
Bancel Stephane USASchrum Jason P USA
WO 2013069780 A1 20130516 Idemitsu Kosan Co Japan Viral infection preventive
115
Nº de publicación Solicitante País de origen Contenido Técnico
WO 2013049382 A2 20130404
Univ Kansas State USA
Broad-spectrum antivi-rals against 3c or 3c-like proteases of picornavirus-like supercluster: picorna-viruses, caliciviruses and coronaviruses
Univ Ohio State USAChang Kyeong-Ok USA
Kim Yunjeong USAGroutas William C USA
Hua Duy USASaif Linda J USA
Wichita State University USA
WO 2013054148 A1 20130418
Fernandez Adrian Hector Antonio Argentina Use of a bismuth ion in
the manufacture of a medicament for the pre-vention and/or treatment of the haemolytic uremic syndrome
Soubeiran Chobet Argentina
Fernandez Hector Manuel Argentina
WO 2013059984 A1 20130502
Univ Northwest A&F China Derivative of methac-ryloyl-benzimidazol-one (thione) and use thereof as anti-microbial drug
Ji Zhiqin ChinaWei Shaopeng China
Wu Wenjun China
WO 2013063695 A1 20130510
Kane Biotech Inc Canada
Compositions and methods for preventing and treating oral diseases
Lovetri Karen CanadaMadhyastha Srinivasa Canada
Yakandawala Nandadeva CanadaGawande Purushottam V Canada
Froehlich Gord Canada
WO 2013067578 A1 20130516
Univ Queensland AustraliaModulators of c3a recep-torsFairlie David Australia
Reid Robert C Australia
WO 2013071457 A1 20130523
Univ Santiago Chile Chile Injectable veterinary composition for contro-lled, sustained release of ceftiofur and florfenicol in animal species, based on polyhydroxybutyrate hydroxyvalerate (phbv) microparticles
Vilos Ortiz Cristian ChileVelasquez Cumplido Luis ChileConstandil Cordova Luis Chile
Rios Ramirez Miguel Chile
WO 2013042964 A2 20130328 Cj Cheiljedang Corp South
Korea
Novel bacteriophage and antibacterial composition comprising the same
CN 102784158 A 20121121
Sichuan Deruntong Biolog Technology Co Ltd China
Preparation method of compound synergy tylo-sin tartrate for veterinary injection
CN 102793713 A 20121128
Shanghai Gongyi Veteri-nary Medicines Plant China
Lincomycin hydrochloride-spectinomycin sulfate injection and preparation method thereof
116
Nº de publicación Solicitante País de origen Contenido Técnico
US 2013085137 A1 20130404
Hydromer Inc USA Topical antimicrobial com-positions and methods of using sameHydromer Inc USA
WO 2013047144 A1 20130404
Nippon Soda Co Japan
Cyclic amine compound and pest control agent
Hamamoto Isami JapanTakahashi Jun JapanIwasa Takao Japan
CN 102836226 A 20121226
Qingdao Lvman Biolog Engineering Co Ltd China
Traditional chinese me-dicine composition for treatment of livestock mastitis, and preparation method thereof
WO 2013074892 A1 20130523 Merial Ltd USA
Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof
WO 2013070981 A2 20130516
Univ Central Florida Res Found USA
Treating er stress related disorders by stabilizing intracellular calcium ho-meostasis
WO 2013051632 A1 20130411 Takeda Pharmaceutical Japan Nitrogen-containing fused
heterocyclic compoundWO 2013042782
A1 20130328 Takeda Pharmaceutical Japan Condensed heterocyclic compound
WO 2013059606 A1 20130425
Tufts Medical Ct Inc USA Compounds and methods for the treatment of mus-cular disease, and related screening methods
Children S Hospital Bos-ton USA
WO 2013078477 A2 20130530
Payne Adam J USA Solubilization of curcu-minoid compounds and products thereof
Kurien Biji T USAScofield R Hal USA
ES 2386474 A1 20120821 Norel Sa Spain Additives for animal food
WO 2013064681 A1 20130510 Galderma Res & Dev France
N-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use
KR 20130010347 A 20130128 Snu R&Db Found South
Korea
Vaccine composition for north american porcine reproductive and respira-tory syndrome virus and mixed vaccine comprising thereof
KR 20130010426 20130128 Snu R&Db Found South
Korea
Vaccine composition for Korean porcine repro-ductive and respiratory syndrome virus
117
Nº de publicación Solicitante País de origen Contenido Técnico
KR 120060645B B1 20130503 Cj Cheiljedang Corp South
Korea
Novel isolated bacte-riophage having E. coli specific antibacterial activity and antibacterial composition comprising the same
KR 20130013712 A 20130206
Lee Seung Jun South Korea
A process for producing animal pharmaceutical comprising natural herbs and having a preventing activity of animal’s diarr-hea
Lee Hyun Jin South Korea
1 VTAvicultura
18
Nº de publicación Solicitante País de origen Contenido Técnico
CN 102603577 A 20120725 Huizhen Dong China
Derivatives of anti-influen-za and anti-avian influenza medicament and applica-tion thereof
CN 102696910 A 20121003
Shandong Newhope Liuhe Group Co Ltd China
Feed composition and tra-ditional Chinese medicine for preventing and treating avian infectious laryngo-tracheitis
CN 102755293 A 20121031
Qingdao Lvman Biolog Engineering Co Ltd China Preparation method of tol-
trazuril solid dispersion
CN 102784364 A 20121121 Chuanjin Zhang China
Pure traditional Chinese medicine powder for pre-venting and treating chic-ken colibacillosis and pre-paration method of pure traditional Chinese medici-ne powder
CN 102772790 A 20121114
Qilu Animal Health Pro-ducts Co Ltd China
Compound echinacea pur-purea preparation and pre-paration method and appli-cation thereof
KR 20130025186 A 20130311 Shinil Biogen Co Ltd South
KoreaAnti-coccidial composition comprising herbal extracts
KR 20130031931 A 20130329 Biopoa Inc South
Korea
Vaccine composition for the protection against avian colibacillosis and method for preparation thereof
CN 102757940 A 20121031 Univ Anhui Agricultural China
Duck flavivirus and prepa-ration and application of inactivated vaccine of duck flavivirus
CN 102793713 A 20121128
Shanghai Gongyi Veteri-nary Medicines Plant China
Lincomycin hydrochloride-spectinomycin sulfate in-jection and preparation method thereof
CN 102793920 A 20121128
Jiangsu Acad Agricultural Sci China
Compound immunopoten-tiator, inactivated vaccine for poultry, and prepara-tion method thereof
19
Nº de publicación Solicitante País de origen Contenido Técnico
CN 102796200 A 20121128 Univ Nanjing China
Hybrid peptide bursin ad-juvant and preparation method and application thereof
CN 102895638 A 20130130
Univ Hebei Normal Sci&Technology China
Chinese herbal medicine oral liquid useful for trea-ting infectious laryngotra-cheitis of chicken
ES 2386474 A1 20120821 Norel Sa Spain Additives for animal food
KR 20120129777 A 20121128
Univ Chonbuk Nat Ind Coop Found
South Korea
Vaccine composition com-prising attenuated and im-munopotentiated mutant of Salmonella enteritidis for preventing salmonello-sis
CN 102885914 A 20130123
Tianjin Shengji Group Co Ltd China
Traditional Chinese medi-cine oral liquid for treating chicken coccidiosis and preparation method the-reof
CN 102846700 A 20130102 Univ Qingdao Agricultural China
Traditional Chinese medi-cine composition used for preventing and treating mixed infection of poultry coccidiosis and necrotic en-teritis
CN 102846709 A 20130102
Tianjin Bijia Pharmaceuti-cal Group Co Ltd China
Chinese veterinary medi-cine composition used for preventing and treating poultry mycoplasmosis and preparation method the-reof
CN 102846781 A 20130102 Wang Hongtao China
Veterinary drug containing Chinese medicines for trea-ting coccidiosis in poultry
EP 2586318 A1 20130501
United Arab Emirates Uni-versity
United Arab
Emirates
Date pit composition for the treatment of animals
KR 20130033043 A 20130403
Univ Konkuk Ind Coop Corp
South Korea
A h9 avian influenza virus-like particle vaccine and a use of the same
WO 2013082327 A1 20130606 Merial Ltd USA
Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof
20
Nº de publicación Solicitante País de origen Contenido Técnico
WO 2013061056 A1 20130502
Univ Exeter United Kingdom
VaccineBirkbeck University Of
LondonUnited
Kingdom
WO 2013053772 A1 20130418 Bevec Dorian Germany
Antimicrobial peptides for treatment of infectious di-seases
WO 2013057236 A1 20130425
Intervet Int Bv Nether-lands Recombinant non-patho-
genic Marek’s disease virus constructs encoding infec-tious laryngotracheitis vi-rus and newcastle disease virus antigens
Cook Stephanie USAMorsey Mohamad USA
Petersen Gary USASondermeijer Paulus Jaco-
bus AntoniusNether-lands
CN 102805772 A 20121205
Henan Xinzhenghao Bio Engineering Co Ltd China
Application of coptis chi-nensis, amur cork-tree bark, Chinese rhubarb and skullcap dysentery inhibi-ting particles to prepara-tion of medicines for trea-ting intestinal diseases of poultry, and medicinal composition formed by compounding particles
CN 102839157 A 20121226 Univ Yangzhou China
MDCK cell system capable of stably coexpressing Hst-3GIIV and beta1-4GalT1 and establishing method and application thereof
CN 102813712 A 20121212
Hebei University Of Engi-neering China
Traditional Chinese medi-cine oral liquid for treating chicken coccidiosis
CN 102813725 A 20121212
Tianjin Shengji Group Co Ltd China
Traditional Chinese medi-cine powder for treating chicken colibacillosis and preparation method the-reof
CN 102813850 A 20121212
Univ Henan Science & Tech China
Traditional Chinese medici-ne composition for preven-ting and treating poultry coccidiosis and preparation method of traditional Chi-nese medicine composition
CN 102813909 A 20121212
Qingdao Lvman Biolog Engineering Co Ltd China
Compound doxycycline hy-drochloride composition for preventing and treating colibacillosis and chronic respiratory disease of poul-try as well as preparation method thereof
121
Nº de publicación Solicitante País de origen Contenido Técnico
CN 102813910 A 20121212
Univ Nanjing Agricultural China Medicine composition used for controlling poultry air-sacculitis, and preparation method thereof
Nanjing Weitai Fama Vete-rinary Res Inst Co Ltd China
CN 102816221 A 20121212
Inst Of Veterinary Medici-ne Guangdong Academy Of Agricultural Sciences
China
Chicken E. tenella MA1 (EtMA1) gene, vector, re-combinant strain, EtMA1 protein, EtMA1-Outside domain, and use of the EtMA1 protein and the Et-MA1-Outside domain
CN 102816222 A 20121212
Inst Of Veterinary Medici-ne Guangdong Academy Of Agricultural Sciences
China
Chicken E.tenella MA2 gene, vector, recombinant strain, protein, and appli-cation thereof
CN 102805275 A 20121205
Shandong Newhope Liuhe Group Co Ltd China
Feed and traditional Chi-nese medicine compound used for treating colibaci-llosis of chicken and prepa-ration method of feed and traditional Chinese medici-ne compound
WO 2013072882 A1 20130523
Actelion Pharmaceuticals Ltd
Switzer-land
2 -amino- 1, 8 -naphthyri-dine-3 -carboxamide de-rivatives as antimicrobial agents
WO 2013071298 A1 20130516
Nutrition Physiology Com-pany Llc USA
Lactic acid bacteria and their use as dietary supple-mentals for poultry
WO 2013075185 A1 20130530
Unicamp Brazil
Attenuated Escherichia coli strains for septicemia in birds, vaccines produced using said strains, method for producing vaccines and uses thereof
Pace Fernanda De BrazilSilveira Wanderley Dias Da Brazil
Stehling Eliana Guedes BrazilLancellotti Marcelo Brazil
Sircili Marcelo Palma BrazilPaiva Jacqueline Boldrin
De Brazil
Nakazato Gerson Brazil
WO 2013054148 A1 20130418
Fernandez Adrian Hector Antonio Argentina Use of a bismuth ion in the
manufacture of a medica-ment for the prevention and/or treatment of the haemolytic uremic syndro-me
Soubeiran Chobet Argentina
Fernandez Hector Manuel Argentina
WO 2013074273 A1 20130523
Academia Sinica USA Bidens pilosa and polyace-tylenic compounds for pre-vention and treatment of coccidiosis
Liang Chi Ming TaiwanYang Wen-Chin TaiwanChang Lee-Tian Taiwan
122
Nº de publicación Solicitante País de origen Contenido Técnico
KR 20130013712 A 20130206
Lee Seung Jun South Korea
A process for producing animal pharmaceutical comprising natural herbs and having a preventing activity of animal’s diarr-hea
Lee Hyun Jin South Korea
WO 2013055674 A1 20130418
Univ Toledo USA
Method for treating infec-tions
Ronning Donald USAFranco Jimmy USA
Kang Choong-Min USA
US 2013065846 A1 20130314
Soll Mark D USA
Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
Rosentel Jr Joseph K USAPate James USA
Shub Natalya USAMotwani-Tejwani Monica USA
Belansky Carol USA
WO 2013063388 A1 20130502
Univ California USA
Diatom-based vaccines
Synaptic Res Llc USACorbeil Lynette B USAHildebrand Mark USAShrestha Roshan USA
Davis Aubrey USASchrier Rachel USAOyler George A USA
Rosenberg Julian N USA
WO 2013074892 A1 20130523 Merial Ltd USA
Compositions compri-sing an aryl pyrazole and a substituted imidazole, methods and uses thereof
WO 2013049272 A2 20130404 Theraceutix Llc USA
Composition and method for treatment of symptoms associated with various skin conditions
WO 2013078477 A2 20130530
Payne Adam J USA Solubilization of curcumi-noid compounds and pro-ducts thereof
Kurien Biji T USAScofield R Hal USA
KR20120097861 A 20120905
Bioinformatics&Molecular Design Res Ce
South Korea
Novel phenylurea or phen-ylthiourea derivatives, pharmaceutically accep-table salts thereof, pre-paration method thereof and pharmaceutical com-position for prevention or treatment of diseases in-duced by influenza virus containing the same as an active ingredient
Equisnzaroo Co Ltd South Korea
123
Nº de publicación Solicitante País de origen Contenido Técnico
WO 2013040649 A1 20130328
Cell Ideas Pty Ltd Australia
Therapeutics using adipose cells and cell secretions
Vesey Graham AustraliaWebster Rebecca Anne Australia
Lilischkis Richard Australia
WO 2013064681 A1 20130510 Galderma Res & Dev France
N-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use
WO 2013069780 A1 20130516 Idemitsu Kosan Co Japan Viral infection preventive
1 VTAcuicultura
24
Nº de publicación Solicitante País de origen Contenido Técnico
CN 102793916 A 20121128
Inst Oceanology Chinese Acad China
Vibrio anguillarum atte-nuated vaccine and its application
CN 102895677 A 20130130
Wuxi Haijian Biological Technology Co China
New prawn multivalent carrier vaccine obtained from Bacillus subtilis re-combinant strain, useful for preventing and treating white spot syndrome virus and Vibrio harveyi
KR 20130013965 A 20130206 Jns Tech Inc South
Korea
Anti-fungal and anti-bac-terial compositions against fish pathogenic bacteria
KR 20130016177 A 20130214
Cheju Nat Univ Ind Acad Coop
South Korea
Antibacterial compositions against fish disease bac-teria
CN 102807987 A 20121205
Liaoning Marine Auatic Product Science Res Inst China
Meretrix intracellular cop-per zinc superoxide dismu-tase gene and application thereof
WO 2013063388 A1 20130502
Univ California USA
Diatom-based vaccines
Synaptic Res Llc USACorbeil Lynette B USAHildebrand Mark USAShrestha Roshan USA
Davis Aubrey USASchrier Rachel USAOyler George A USA
Rosenberg Julian N USA
US 2013121978 A1 20130516
Marrone Bio Innovations Inc USA Chemical and biological
agents for the control of molluscsMarrone Bio Innovations
Inc USA
KR 120048946B B1 20130402 Daebong Ls Ltd South
Korea
A pharmaceutical compo-sition for treating a bac-terially caused disease of fish
25
Nº de publicación Solicitante País de origen Contenido Técnico
EP 2586318 A1 20130501
United Arab Emirates Uni-versity
United Arab
Emirates
Date pit composition for the treatment of animals
WO 2013078477 A2 20130530
Payne Adam J USA Solubilization of curcu-minoid compounds and products thereof
Kurien Biji T USAScofield R Hal USA
WO 2013074273 A1 20130523
Academia Sinica USA Bidens pilosa and polya-cetylenic compounds for prevention and treatment of coccidiosis
Liang Chi Ming TaiwanYang Wen-Chin TaiwanChang Lee-Tian Taiwan
1 VTApicultura
26
Nota: No se han detectado solicitudes de patentes publicadas en el ámbito de la apicultu-ra en este periodo de tiempo.
1 VTÉquidos
27
Nº de publicación Solicitante País de origen Contenido Técnico
JP 2013099339 A 20130523
Wisconsin Alumni Res Found Japan
New isolated equine in-fluenza virus H3 useful for immunizing mammal cho-sen from dog and horse comprises hemagglutinin comprising specific amino acid sequence
US 2013065846 A1 20130314
Soll Mark D USA
Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
Rosentel Jr Joseph K USAPate James USA
Shub Natalya USAMotwani-Tejwani Monica USA
Belansky Carol USA
WO 2013052001 A1 20130411 Delaval Holding Ab Sweden
Method and apparatus for detecting lameness in livestock
WO 2013040649 A1 20130328
Cell Ideas Pty Ltd AustraliaTherapeutics using adi-pose cells and cell secre-tions
Vesey Graham AustraliaWebster Rebecca Anne Australia
Lilischkis Richard Australia
CN 102816732 A 20121212
Beijing Jianxiang Hemu Biolog Technology Co Ltd China MDCK cell line suitable for
full suspended serum-free culture and its application in culturing of influenza virus and production of influenza virus vaccines
Shanxi Longkeer Biolog Pharmaceutical Co Ltd China
WO 2013063388 A1 20130502
Univ California USA
Diatom-based vaccines
Synaptic Res Llc USACorbeil Lynette B USAHildebrand Mark USAShrestha Roshan USA
Davis Aubrey USASchrier Rachel USAOyler George A USA
Rosenberg Julian N USA
128
Nº de publicación Solicitante País de origen Contenido Técnico
WO 2013074892 A1 20130523 Merial Ltd USA
Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof
WO 2013069780 A1 20130516 Idemitsu Kosan Co Japan Viral infection preventive
KR 20120117715 A 20121024
Daesung Microbiological Labs Co Ltd
South Korea
Functional antibiotic complex composition for animal use
WO 2013055674 A1 20130418
Univ Toledo USA
Method for treating infec-tions
Ronning Donald USAFranco Jimmy USA
Kang Choong-Min USA
WO 2013072882 A1 20130523
Actelion Pharmaceuticals Ltd
Switzer-land
2 -amino- 1, 8 -na-phthyridine-3 -carboxami-de derivatives as antimi-crobial agents
WO 2013054148 A1 20130418
Fernandez Adrian Hector Antonio Argentina Use of a bismuth ion in
the manufacture of a medicament for the pre-vention and/or treatment of the haemolytic uremic syndrome
Soubeiran Chobet Argentina
Fernandez Hector Manuel Argentina
WO 2013063695 A1 20130510
Kane Biotech Inc Canada
Compositions and methods for preventing and treating oral diseases
Lovetri Karen CanadaMadhyastha Srinivasa Canada
Yakandawala Nandadeva CanadaGawande Purushottam V Canada
Froehlich Gord Canada
WO 2013067578 A1 20130516
Univ Queensland AustraliaModulators of c3a recep-torsFairlie David Australia
Reid Robert C Australia
EP 2586318 A1 20130501
United Arab Emirates Uni-versity
United Arab
Emirates
Date pit composition for the treatment of animals
WO 2013051632 A1 20130411 Takeda Pharmaceutical Japan Nitrogen-containing fused
heterocyclic compoundWO 2013042782
A1 20130328 Takeda Pharmaceutical Japan Condensed heterocyclic compound
WO 2013059437 A1 20130425 Mars Inc USA
Inhibitors of arginase and their therapeutic applica-tions
WO 2013059606 A1 20130425
Tufts Medical Ct Inc USA Compounds and methods for the treatment of mus-cular disease, and related screening methods
Children S Hospital Boston USA
129
Nº de publicación Solicitante País de origen Contenido Técnico
DE 102011055815 A1 20130529 Aicuris Gmbh & Co Kg Germany
Carboxamide-substituted heteroaryl pyrazoles and their use
WO 2013078477 A2 20130530
Payne Adam J USA Solubilization of curcu-minoid compounds and products thereof
Kurien Biji T USAScofield R Hal USA
WO 2013069765 A1 20130516 Kyowa Hakko Kirin Co Ltd Japan Nitrogenated heterocyclic
compound
US 2013078217 A1 20130328
Wang Guoqiang USA 2’-chloroacetylenyl subs-tituted nucleoside deriva-tives
Kim In Jong USAOr Yat Sun USA
WO 2013064681 A1 20130510 Galderma Res & Dev France
N-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use
1 VTMascotas
30
Nº de publicación Solicitante País de origen Contenido Técnico
WO 2013040142 A2 20130321
Iogenetics Llc USA Bioinformatic processes for determination of pep-tide binding
Bremel Robert D USAHoman Jane USA
WO 2013051632 A1 20130411 Takeda Pharmaceutical Japan Nitrogen-containing fused
heterocyclic compoundWO 2013042782
A1 20130328 Takeda Pharmaceutical Japan Condensed heterocyclic compound
WO 2013047144 A1 20130404
Nippon Soda Co Japan
Cyclic amine compound and pest control agent
Hamamoto Isami JapanTakahashi Jun JapanIwasa Takao Japan
US 2013071385 A1 20130321 Hansen Genevieve USA Monoclonal antibodies
US 2013065846 A1 20130314
Soll Mark D USA
Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
Rosentel Jr Joseph K USAPate James USA
Shub Natalya USAMotwani-Tejwani Monica USA
Belansky Carol USA
WO 2013059437 A1 20130425 Mars Inc USA
Inhibitors of arginase and their therapeutic applica-tions
WO 2013050947 A1 20130411
Uni Degli Studi Di Came-rino Italy
Composition comprising Bacillus calmette guerin with cox2 selective/prefe-rential inhibitor and uses thereof
WO 2013059606 A1 20130425
Tufts Medical Ct Inc USA Compounds and methods for the treatment of mus-cular disease, and related screening methods
Children S Hospital Boston USA
WO 2013040649 A1 20130328
Cell Ideas Pty Ltd AustraliaTherapeutics using adi-pose cells and cell secre-tions
Vesey Graham AustraliaWebster Rebecca Anne Australia
Lilischkis Richard AustraliaWO 2013062028
A1 20130502 Shionogi & Co Japan Hiv replication inhibitor
131
Nº de publicación Solicitante País de origen Contenido Técnico
WO 2013063388 A1 20130502
Univ California USA
Diatom-based vaccines
Synaptic Res Llc USACorbeil Lynette B USAHildebrand Mark USAShrestha Roshan USA
Davis Aubrey USASchrier Rachel USAOyler George A USA
Rosenberg Julian N USA
WO 2013072882 A1 20130523
Actelion Pharmaceuticals Ltd
Switzer-land
2 -amino- 1, 8 -na-phthyridine-3 -carboxa-mide derivatives as antimicrobial agents
WO 2013074892 A1 20130523 Merial Ltd USA
Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof
US 2013131016 A1 20130523
Anacor Pharmaceuticals Inc USA Boron-containing small
moleculesLilly Co Eli USA
WO 2013069765 A1 20130516 Kyowa Hakko Kirin Co Ltd Japan Nitrogenated heterocyclic
compound
WO 2013049272 A2 20130404 Theraceutix Llc USA
Composition and method for treatment of symp-toms associated with various skin conditions
US 2013072455 A1 20130321
Piedmont Pharmaceuticals Llc USA
Methods and composi-tions for treating ectopa-rasite infestation
Campbell William R USAPalma Kathleen G USA
Paulsen Neil E
WO 2013054127 A1 20130418 Nvip Pty Ltd Australia
Canine/feline cd20 bin-ding epitope and compo-sitions for binding thereto
US 2013131017 A1 20130523
Anacor Pharmaceuticals Inc USA Boron-containing small
moleculesLilly Co Eli USA
WO 2013067578 A1 20130516
Univ Queensland AustraliaModulators of c3a recep-torsFairlie David Australia
Reid Robert C Australia
US 2013078217 A1 20130328
Wang Guoqiang USA 2’-chloroacetylenyl subs-tituted nucleoside deriva-tives
Kim In Jong USAOr Yat Sun USA
132
Nº de publicación Solicitante País de origen Contenido Técnico
WO 2013064681 A1 20130510 Galderma Res & Dev France
N-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use
WO 2013055674 A1 20130418
Univ Toledo USA
Method for treating infec-tions
Ronning Donald USAFranco Jimmy USA
Kang Choong-Min USA
WO 2013049382 A2 20130404
Univ Kansas State USA
Broad-spectrum antivi-rals against 3c or 3c-like proteases of picornavirus-like supercluster: picor-naviruses, caliciviruses and coronaviruses
Univ Ohio State USAChang Kyeong-Ok USA
Kim Yunjeong USAGroutas William C USA
Hua Duy USASaif Linda J USA
Wichita State University USA
WO 2013063695 A1 20130510
Kane Biotech Inc Canada
Compositions and methods for preventing and treating oral diseases
Lovetri Karen CanadaMadhyastha Srinivasa Canada
Yakandawala Nandadeva CanadaGawande Purushottam V Canada
Froehlich Gord Canada
WO 2013070981 A2 20130516
Univ Central Florida Res Found USA
Treating er stress related disorders by stabilizing intracellular calcium ho-meostasis
WO 2013078477 A2 20130530
Payne Adam J USA Solubilization of curcu-minoid compounds and products thereof
Kurien Biji T USAScofield R Hal USA
KR 20130025186 A 20130311 Shinil Biogen Co Ltd South
Korea
Anti-coccidial composition comprising herbal ex-tracts
ES 2386474 A1 20120821 Norel Sa Spain Additives for animal food
JP 2013099339 A 20130523
Wisconsin Alumni Res Found Japan
New isolated equine influenza virus H3 useful for immunizing mammal chosen from dog and horse comprises hema-gglutinin comprising spe-cific amino acid sequence
1 VTVarios
33
Nº de publicación Solicitante País de origen Contenido Técnico
WO 2013049382 A2 20130404
Univ Kansas State USA
Broad-spectrum antivirals against 3c or 3c-like pro-teases of picornavirus-like supercluster: picornavi-ruses, caliciviruses and coronaviruses
Univ Ohio State USAChang Kyeong-Ok USA
Kim Yunjeong USAGroutas William C USA
Hua Duy USASaif Linda J USA
Wichita State University USA
WO 2013067578 A1 20130516
Univ Queensland AustraliaModulators of c3a recep-torsFairlie David Australia
Reid Robert C Australia
KR 20130013712 A 20130206
Lee Seung Jun South Korea
A process for producing animal pharmaceutical comprising natural herbs and having a preventing activity of animal’s diarr-hea
Lee Hyun Jin South Korea
US 2013085137 A1 20130404 Hydromer Inc USA
Topical antimicrobial com-positions and methods of using same
WO 2013052174 A2 20130411
Univ Pennsylvania USA Methods for preventing and treating Staphylococcus aureus colonization, infec-tion, and disease
Weiser Jeffrey USA
Lijek Rebeccah S USA
WO 2013047144 A1 20130404
Nippon Soda Co Japan
Cyclic amine compound and pest control agent
Hamamoto Isami JapanTakahashi Jun JapanIwasa Takao Japan
WO 2013055674 A1 20130418
Univ Toledo USA
Method for treating infec-tions
Ronning Donald USAFranco Jimmy USA
Kang Choong-Min USA
34
Nº de publicación Solicitante País de origen Contenido Técnico
WO 2013063388 A1 20130502
Univ California USA
Diatom-based vaccines
Synaptic Res Llc USACorbeil Lynette B USAHildebrand Mark USAShrestha Roshan USA
Davis Aubrey USASchrier Rachel USAOyler George A USA
Rosenberg Julian N USA
WO 2013070981 A2 20130516
Univ Central Florida Res Found USA
Treating er stress related disorders by stabilizing intracellular calcium ho-meostasis
WO 2013051632 A1 20130411 Takeda Pharmaceutical Japan Nitrogen-containing fused
heterocyclic compoundWO 2013042782
A1 20130328 Takeda Pharmaceutical Japan Condensed heterocyclic compound
WO 2013059437 A1 20130425 Mars Inc USA
Inhibitors of arginase and their therapeutic applica-tions
WO 2013059606 A1 20130425
Tufts Medical Ct Inc USA Compounds and methods for the treatment of mus-cular disease, and related screening methods
Children S Hospital Bos-ton USA
WO 2013078477 A2 20130530
Payne Adam J USA Solubilization of curcu-minoid compounds and products thereof
Kurien Biji T USAScofield R Hal USA
WO 2013069765 A1 20130516 Kyowa Hakko Kirin Co Ltd Japan Nitrogenated heterocyclic
compound
US 2013136775 A1 20130530
Voigt Andreas GermanyHydrophobic drug-delivery material, method for ma-nufacturing thereof and methods for delivery of a drug-delivery composition
Kriwanek Joerg GermanyHampton Scott USAReiff Andreas USALudwig Sonja Germany
EP 2572728 A1 20130327 Vivalis France
Duck embryonic derived stem cell lines for the pro-duction of viral vaccines
CN 102830225 A 20121219
Chinese Ct For Animal Disease Control And Pre-
ventionChina
Hemagglutinin and immu-nizing antigen from natura-lly avirulent strain of avian influenza virus
WO 2013074273 A1 20130523
Academia Sinica USA Bidens pilosa and polya-cetylenic compounds for prevention and treatment of coccidiosis
Liang Chi Ming TaiwanYang Wen-Chin TaiwanChang Lee-Tian Taiwan
135
Nº de publicación Solicitante País de origen Contenido Técnico
WO 2013062028 A1 20130502 Shionogi & Co Japan Hiv replication inhibitor
US 2013078217 A1 20130328
Wang Guoqiang USA 2’-chloroacetylenyl substi-tuted nucleoside derivati-ves
Kim In Jong USAOr Yat Sun USA
WO 2013064681 A1 20130510 Galderma Res & Dev France
N-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use
WO 2013049352 A2 20130404 Kineta Inc USA Anti-viral compounds
CN 102875673 A 20130116
Tianjin Zhonsheng Cha-llenge Biolog Engineering
Co LtdChina
Preparation method of egg yolk antibody for treating multocida pasteurellosis
CN 102766640 A 20121107
Beijing Jianxiang Hemu Biolog Technology Co Ltd China
Method for preparing in-fluenza A virus full-length M2 protein
WO 2013064818 A1 20130510
Dupont Nutrition Biosci Aps Denmark
AptamersUniv Chester United
Kingdom
WO 2013054329 A1 20130418 Yeda Res & Dev Israel
Toll-like receptor 4 (tlr-4) agonist peptides for mo-dulating tlr-4 mediated immune response
WO 2013049407 A2 20130404 Kineta Inc USA Anti-viral compounds
24
Noticias
Campaña de sensibilización: concurso de diseño de carteles como lucha contra la falsificación.Para incentivar la capacidad creativa de diseñadores y emprendedores, ANDEMA, con apoyo de la OEPM, lanzó un concurso de carteles destinado a premiar el me-jor diseño de cartel relativo a la lucha contra las falsificaciones para que fuese la imagen Día Mundial Antifalsificación del pasado 7 de Junio.
Diseños a escena
Es posible proteger como Diseño Industrial el diseño de un escenario, su ilumina-ción, la disposición y forma de los elementos que lo conforman. También pueden protegerse los decorados para teatro y espectáculos en general (ópera, musica-les, platós o sets para series, programas de televisión).
Máster en Gestión Integral de la Marca. Fundación PONS y Universidad Rey Juan Carlos. Octubre-Junio 2013-2014. MadridLa Fundación Pons y la Universidad Rey Juan Carlos, en colaboración con la OEPM, la Asociación Nacional para la Defensa de la Marca (ANDEMA), Interbrand y la Asociación de Marketing de España, organizan este primer Máster en España centrado en la figura de la Marca desde una perspectiva global.
Croacia, Chipre, México y Noruega se suman a la herramienta de búsqueda TM-viewDesde el 1 de julio de 2013, cuatro nuevas Oficinas Nacionales ponen sus datos de Signos Distintivos a disposición de la herramienta de búsqueda TMview sien-do Chipre y Croacia países miembros de la UE y México y Noruega, los primeros países colaboradores no pertenecientes a la UE
36
Conferencia contra falsificación de medicamentosLos días 26 a 28 de junio, el Observatorio Europeo de las Vulneraciones de los Derechos de la Propiedad Intelectual, y la EUROPOL organizan conjuntamente una gran conferencia en Alicante contra el negocio de medicamentos falsificados y productos de farmacia ilícitos, ya que éste constituye una importante amenaza a la salud y a la seguridad pública de Europa.
Diseños que protegen obras de arteNo hay nada en la Ley de Diseños o en la Directiva sobre Modelos y Dibujos industriales que impidan la protección de obras de arte como esculturas. Ac-tualmente, en la base de datos Designview existen 268 diseños bajo el epígrafe “Escultura”
6 nuevos idiomas en Patent Translate.
La Oficina Europea de Patentes (EPO) ha incluido 6 nuevos idiomas en su servicio gratuito Patent Translate para mejorar el acceso a la información contenida en los documentos de patente. Los nuevos idomas son bulgaro, checo, rumano, eslova-co, islandés y esloveno.
España recupera tres posiciones en el índice mundial de innovación 2013 publica-do por OMPISegún el Índice Mundial de Innovación 2013, publicado el pasado 1 de Julio conjuntamente por la Organización Mundial de la Propiedad Intelectual (OMPI), la Universidad Cornell y el INSEAD, España ha recuperado tres posiciones con respecto al año 2012, pasando a ocupar el puesto 26.
24
Noticias
España y las patentes sobre energías renovables 2000-2012
La OEPM ha elaborado un estudio relativo a las solicitudes de patentes de origen español en el sector de las energías renovables que nos permite conocer nuestra situación a nivel nacional, europeo y mundial
Día Mundial Antifalsificación
En el transcurso de la cita, la Directora General de la OEPM presentó el informe ‘La actitud del consumidor frente a las falsificaciones’ realizado por el Servicio de Estudios del Consejo Superior de Cámaras.
El español José Luis López gana la votación popular del Premio al Inventor Euro-peo 2013
El voto popular reconoce el diseño de un sistema de control de contacto entre rueda y raíl en trenes de alta velocidad (Independent wheel guidance for High Speed Trains).
Nuevo Boletín de Vigilancia Tecnológica sobre Energías Marinas
La publicación tiene como objetivo facilitar información trimestralmente sobre las últimas noticias y solicitudes de patentes publicadas en este sector técnico y así mantener informadas a empresas, PYME y organismos públicos.
37
Subvenciones para fomentar las solicitudes de patentes y modelos de utilidadLa Oficina Española de Patentes y Marcas ha publicado la convocatoria de subven-ciones para fomentar las solicitudes de patentes y modelos de utilidad españolas, también en el exterior. El plazo de presentación de solicitudes fue del 5 de junio al 4 del julio de 2013.
Modificación de la Concesión Acelerada de Patentes (CAP)
La novedad consiste en la no exclusión automática del programa de aquellas soli-citudes de patentes que sean objeto de un suspenso formal o técnico.
Firma de convenios de colaboración en materia de Propiedad Industrial
El objetivo es establecer un marco de cooperación de la OEPM con diversas enti-dades con el fin de facilitar, impulsar y estimular el conocimiento y la utilización de los derechos de Propiedad Industrial.
25
Noticias
38
Vet+i colabora con Asebio en la difusión de BIOLATAM 2013
BIOLATAM 2013 una iniciativa impulsada por ASEBIO para fomentar desarrollo de negocio entre empresas biotecnológicas y entre éstas y las de sectores usuarios como el de la sanidad animal con intereses en el área Latinoamericana.
El MINECO organiza una Jornada sobre Infraestructuras Científicas y Tecnológicas Singulares dedicada a las Plataformas Tecnológicas
Vet+i asiste a la Jornada organizada por el MINECO para debatir sobre las ICTS, su difusión y las oportunidades que ofrecen al sector industrial.
La Plataforma Vet+i pone en marcha ‘Vetresponsable’Vet+i pretende reforzar el uso responsable de los medicamentos veterinarios en España y el sistema de farmacovigilancia veterinaria a través del impulso de ac-tuaciones de formación y comunicación dirigidas a los veterinarios, los ganaderos y los propietarios de mascotas.
Vet+i reúne a más de 200 expertos de sanidad animal y salud pública en su V Conferencia Anual
La Secretaria de Estado de I+D+i, Carmen Vela, fue la encargada de clausurar este evento, que se ha consolidado como foro de referencia sobre I+D+i en sani-dad animal en España.
Vet+i se reúne con la nueva Subdirectora General de Colaboración Público-Priva-daDurante la reunión se presentaron los principales hitos y actuaciones de la Pla-taforma así como su plan de acción para los próximos meses y se departió sobre diversas iniciativas de interés común.
Vet+i asiste a la V Asamblea de la Plataforma Tecnológica Española de la Pesca y la Acuicultura (PTEPA)Esta actividad se incluye el conjunto de actividades de coordinación y coopera-ción con otras Plataformas Tecnológicas para fomentar la cooperación tecnológica intersectorial.
Vet+i asiste a una Jornada de información sobre Horizon 2020Vet+i asistió a una Jornada organizada por la Fundación madri+d, en colabora-ción con el Centro para el Desarrollo Tecnológico Industrial (CDTI) y las Direc-ciones Generales de Universidades e Investigación y de Asuntos Europeos de la Comunidad de Madrid.
Mª de los Ángeles Ferre, nombrada nueva Subdirectora General de Colaboración Público-PrivadaMª de los Ángeles Ferre, quien desde el 1 de mayo es la nueva Subdirectora Ge-neral de Colaboración Público-Privada en el Ministerio de Economía y Competitivi-dad, es Ingeniero de Minas por la E.T.S. de Ingenieros de Minas de Madrid, siendo su especialidad la de Energía y Combustibles.
25
Noticias
39
Víctor Briones Dieste, nuevo Director del CISA-INIAEste mes de junio el Dr. Víctor Briones Dieste ha sido nombrado como nuevo Director del Centro de Investigación en Sanidad Animal del Instituto Nacional de Investigación Agraria y Alimentaria, sustituyendo en el cargo a José María Nieto Martínez.
Ya está disponible el Informe de Actividad de Vet+i de 2012
Desde la Secretaria de Vet+i se ha elaborado un informe sobre las actividades realizadas por la Plataforma durante el 2012, que está disponible en la web de Vet+i dentro de la carpeta de Documentos y Publicaciones.
Proyecto financiado por:
C/ San Agustín 15-1º Dcha.28014 Madrid
Tlfno: (+34) 91 369 21 34Fax: (+34) 91 369 39 67 secretaria@vetmasi.es
www.vetmasi.es